| Jak2 deficiency defines an essentialdevelopmental checkpoint in definitivehematopoiesis H Neubauer, A Cumano, M Müller, H Wu, U Huffstadt, K Pfeffer Cell 93 (3), 397-409, 1998 | 1134 | 1998 |
| Partial impairment of cytokine responses in Tyk2-deficient mice M Karaghiosoff, H Neubauer, C Lassnig, P Kovarik, H Schindler, ... Immunity 13 (4), 549-560, 2000 | 510 | 2000 |
| Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and … CS Schuetz, M Bonin, SE Clare, K Nieselt, K Sotlar, M Walter, T Fehm, ... Cancer research 66 (10), 5278-5286, 2006 | 383 | 2006 |
| Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma C Lengerke, T Fehm, R Kurth, H Neubauer, V Scheble, F Müller, ... BMC cancer 11, 1-10, 2011 | 274 | 2011 |
| Listeriosis in p47phox−/− and TRp55−/− mice: protection despite absence of ROI and susceptibility despite presence of RNI R Endres, A Luz, H Schulze, H Neubauer, A Fütterer, SM Holland, ... Immunity 7 (3), 419-432, 1997 | 165 | 1997 |
| Comparison of HER2 status between primary tumor and disseminated tumor cells in␣ primary breast cancer patients EF Solomayer, S Becker, G Pergola-Becker, R Bachmann, B Krämer, ... Breast cancer research and treatment 98, 179-184, 2006 | 160 | 2006 |
| Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1 H Neubauer, SE Clare, W Wozny, GP Schwall, S Poznanović, ... Breast Cancer Research 10, 1-16, 2008 | 158 | 2008 |
| Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer S Wei, L Liu, J Zhang, J Bowers, GAN Gowda, H Seeger, T Fehm, ... Molecular oncology 7 (3), 297-307, 2013 | 154 | 2013 |
| Expression of stem cell and epithelial‐mesenchymal transition markers in circulating tumor cells of breast cancer patients N Krawczyk, F Meier-Stiegen, M Banys, H Neubauer, E Ruckhaeberle, ... BioMed research international 2014 (1), 415721, 2014 | 121 | 2014 |
| EpCAM-independent enrichment of circulating tumor cells in metastatic breast cancer H Schneck, B Gierke, F Uppenkamp, B Behrens, D Niederacher, ... PloS one 10 (12), e0144535, 2015 | 119 | 2015 |
| ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients T Fehm, N Krawczyk, EF Solomayer, G Becker-Pergola, S Dürr-Störzer, ... Breast cancer research 10, 1-8, 2008 | 110 | 2008 |
| A bead-based western for high-throughput cellular signal transduction analyses F Treindl, B Ruprecht, Y Beiter, S Schultz, A Döttinger, A Staebler, ... Nature communications 7 (1), 12852, 2016 | 108 | 2016 |
| Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium JM Shillingford, K Miyoshi, GW Robinson, SL Grimm, JM Rosen, ... Molecular endocrinology 16 (3), 563-570, 2002 | 106 | 2002 |
| GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy A Mukha, U Kahya, A Linge, O Chen, S Löck, V Lukiyanchuk, S Richter, ... Theranostics 11 (16), 7844, 2021 | 96 | 2021 |
| Changes in tumour biological markers during primary systemic chemotherapy (PST) H Neubauer, C Gall, U Vogel, R Hornung, D Wallwiener, E Solomayer, ... Anticancer research 28 (3B), 1797-1804, 2008 | 96 | 2008 |
| Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells X Ruan, H Neubauer, Y Yang, H Schneck, S Schultz, T Fehm, MA Cahill, ... Climacteric 15 (5), 467-472, 2012 | 95 | 2012 |
| Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients H Schneck, C Blassl, F Meier-Stiegen, RP Neves, W Janni, T Fehm, ... Molecular oncology 7 (5), 976-986, 2013 | 93 | 2013 |
| Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection C Henneges, D Bullinger, R Fux, N Friese, H Seeger, H Neubauer, ... BMC cancer 9, 1-11, 2009 | 92 | 2009 |
| Gene expression profiling of single circulating tumor cells in ovarian cancer–Establishment of a multi-marker gene panel C Blassl, JD Kuhlmann, A Webers, P Wimberger, T Fehm, H Neubauer Molecular oncology 10 (7), 1030-1042, 2016 | 91 | 2016 |
| Breast cancer proteomics by laser capture microdissection, sample pooling, 54‐cm IPG IEF, and differential iodine radioisotope detection H Neubauer, SE Clare, R Kurek, T Fehm, D Wallwiener, K Sotlar, ... Electrophoresis 27 (9), 1840-1852, 2006 | 91 | 2006 |
Rui Lousa das NevesUniklinikum DusseldorfVerified email at med.uni-duesseldorf.de
